NEWS | INNOVATION
FDA Clears 1st Spinopelvic Fixation System with Nanotechnology Designation .
A new approach to sacroiliac joint fixation has received regulatory clearance. Xenix Medical's Riva Anchor system is designed for use at the base of posterior lumbar or thoracolumbar fusion constructs, incorporating a proprietary micro- and nanoscale surface intended to support bone growth. The company is preparing for a limited commercial launch. While the technology introduces another fixation option for complex spine surgery, its comparative fusion rates, implant longevity and clinical outcomes require further evaluation.
Read the full News article from Becker's Spine Review
Read ArticleDISCLAIMER
This content found on this page is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. If you require medical treatment, always seek the advice of your physician or go to your nearest emergency department. The opinions, beliefs, and viewpoints expressed by the individuals on the content found on this page do not reflect the opinions, beliefs, and viewpoints of OrthoEvidence.